Tilray reported $12.83M in Interest Income for its fiscal quarter ending in May of 2024.





Interest Income Change Date
Acasti Pharma USD -0.36 172K Dec/2024
Aurora Cannabis CAD 1.85M 120K Sep/2025
Cronos Group USD 9.56M 2.18M Dec/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
IQVIA Holdings USD 10M 1000K Mar/2026
Knight Therapeutics CAD 2.46M 498K Sep/2024
Moderna USD 70M 3M Dec/2025
Revvity USD 5.75M 5.75M Dec/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Tilray USD 12.83M 20.19M May/2024
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025